🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

83+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 83 recruiting trials for “Glioblastoma

NARecruitingNCT06797661

Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.

👨‍⚕️ Xavier De Tiège, MD,PhD, Laboratoire de Neuroanatomie et Neuroimagerie translationnelles Université Libre de Bruxelles📍 1 site📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT05439278

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

👨‍⚕️ Chan Woo Wee, MD, PhD, Severance Hospital📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06936046

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06625684

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

👨‍⚕️ Quinn Ostrom, PhD, Duke University📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06630260

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

👨‍⚕️ Juanita Lopez, MD, PhD, National Health Service, UK📍 3 sites📅 Started Nov 2024View details ↗
RecruitingNCT06796335

Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour

🏥 Rigshospitalet, Denmark📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06632236

5G-EMERALD: Amivantamab in Malignant Brain Tumours

👨‍⚕️ Juanita Lopez, MD, PhD, National Health Service, UK📍 2 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06975332

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

👨‍⚕️ Przemysław Kunert, Professor, Department of Neurosurgery, Medical University of Warsaw, Poland📍 2 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06222138

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

🏥 Institut Claudius Regaud📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06512311

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening

🏥 Medical University of Vienna📍 1 site📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT06186401

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

👨‍⚕️ Jennifer Clarke, MD, MPH, University of California, San Francisco📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT05768087

Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients

👨‍⚕️ Anouk K Trip, MD PhD, Danish Centre for Particle Therapy📍 2 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT05871021

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma

👨‍⚕️ Maximilian Niyazi, Prof. Dr., University Hospital Tuebingen, Department of Radiation Oncology📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06623565

Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques

🏥 Amsterdam UMC, location VUmc📍 1 site📅 Started Apr 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT06690216

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

👨‍⚕️ Man Hu, Dr., Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences: Shandong Cancer Hospital and Institute📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06418113

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

🏥 Hospital San Carlos, Madrid📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT05736406

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

👨‍⚕️ Jan Drappatz, MD, UPMC Presbyterian Shadyside Hospital, Pittsburgh, PA📍 2 sites📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06039709

Sonodynamic Therapy in Patients With Recurrent GBM

👨‍⚕️ Shayan Moosa, MD, UVA📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06108206

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

👨‍⚕️ Tony J. Wang, MD, Columbia University📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06710249

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

🏥 Peter Siesjö📍 1 site📅 Started Jan 2024View details ↗
← PreviousPage 2 of 5Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →